These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 35910226)

  • 1. Relevance of RNA N6-Methyladenosine Regulators for Pulmonary Fibrosis: Implications for Chronic Hypersensitivity Pneumonitis and Idiopathic Pulmonary Fibrosis.
    Zhou Y; Fang C; Sun Q; Dong Y
    Front Genet; 2022; 13():939175. PubMed ID: 35910226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of M6A regulators on diagnosis, subtype classification, prognosis and novel therapeutic target development of idiopathic pulmonary fibrosis.
    Huang G; Huang S; Cui H
    Front Pharmacol; 2022; 13():993567. PubMed ID: 36518679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-methyladenosine regulators play a crucial role in development of chronic hypersensitivity pneumonitis and idiopathic pulmonary fibrosis.
    Zhou Y; Hu Z; Sun Q; Dong Y
    Sci Rep; 2023 Apr; 13(1):5941. PubMed ID: 37045913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of RNA N6-Methyladenosine Regulators in the Diagnosis and Subtype Classification of Childhood Asthma Using the Gene Expression Omnibus Database.
    Dai B; Sun F; Cai X; Li C; Liu H; Shang Y
    Front Genet; 2021; 12():634162. PubMed ID: 33763115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genes related to N6-methyladenosine in the diagnosis and prognosis of idiopathic pulmonary fibrosis.
    Zhang J; Zhang Y; Wang Z; Zhao J; Li Z; Wang K; Tian L; Yao B; Wu Q; Wang T; Wang J
    Front Genet; 2022; 13():1102422. PubMed ID: 36685949
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of the N6-methyladenosine regulatory factor in reducing the risk of cardiovascular disease: subtype diagnosis following aerobic exercise-assisted weight loss.
    Hao X; Li Y; Huang G; Zeng Y
    Am J Transl Res; 2022; 14(8):5363-5378. PubMed ID: 36105062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N6-methyladenosine regulator-mediated methylation modification patterns and immune infiltration characterization in Polycystic Ovary Syndrome (PCOS).
    Zhou S; Hua R; Quan S
    J Ovarian Res; 2023 Apr; 16(1):73. PubMed ID: 37046273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corrigendum: Relevance of RNA N6-methyladenosine regulators for pulmonary fibrosis: Implications for chronic hypersensitivity pneumonitis and idiopathic pulmonary fibrosis.
    Zhou Y; Fang C; Sun Q; Dong Y
    Front Genet; 2022; 13():1056103. PubMed ID: 36330436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N6-Methyladenosine Modification Participates in the Progression of Hepatitis B Virus-Related Liver Fibrosis by Regulating Immune Cell Infiltration.
    Zhao T; Qi J; Liu T; Wu H; Zhu Q
    Front Med (Lausanne); 2022; 9():821710. PubMed ID: 35308519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic signature, subtype classification, and immune infiltration of key m6A regulators in osteomyelitis patients.
    Shi X; Ni H; Wu Y; Guo M; Wang B; Zhang Y; Zhang B; Xu Y
    Front Genet; 2022; 13():1044264. PubMed ID: 36544487
    [No Abstract]   [Full Text] [Related]  

  • 11. m6A regulator-mediated RNA methylation modification patterns are involved in the regulation of the immune microenvironment in ischaemic cardiomyopathy.
    Zheng PF; Hong XQ; Liu ZY; Zheng ZF; Liu P; Chen LZ
    Sci Rep; 2023 Apr; 13(1):5904. PubMed ID: 37041267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recognition of the Subtypes Classification and Diagnostic Signature Based on RNA N6-Methyladenosine Regulators in Recurrent Spontaneous Abortion.
    Wang Z; Dai F; Liu H; Cheng Y
    Reprod Sci; 2023 Dec; 30(12):3537-3547. PubMed ID: 37488406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of N6-Methyladenosine RNA Methylation Regulators in Immune Infiltrates of Ovarian Cancer.
    Gu J; Bi F
    Front Genet; 2021; 12():671179. PubMed ID: 34306015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. m6A regulator-mediated methylation modification patterns and immune microenvironment infiltration characterization in osteoarthritis.
    Hu S; Shen C; Yao X; Zou Y; Wang T; Sun X; Nie M
    BMC Med Genomics; 2022 Dec; 15(1):273. PubMed ID: 36585683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of RNA N6-methyladenosine regulation in epilepsy: Significance of the cell death mode, glycometabolism, and drug reactivity.
    Liu X; Sun Q; Cao Z; Liu W; Zhang H; Xue Z; Zhao J; Feng Y; Zhao F; Wang J; Wang X
    Front Genet; 2022; 13():1042543. PubMed ID: 36468034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of RNA N6-methyladenosine regulators in the diagnosis and subtype classification of coronary heart disease using the Gene Expression Omnibus database.
    Jiang Y; Pan Y; Long T; Qi J; Liu J; Zhang M
    Front Cardiovasc Med; 2023; 10():1185873. PubMed ID: 37928762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analyses of m6A RNA methylation patterns and related immune microenvironment in idiopathic pulmonary arterial hypertension.
    Gao G; Chen A; Gong J; Lin W; Wu W; Mohammad Ismail Hajary S; Lian G; Luo L; Xie L
    Front Genet; 2023; 14():1222368. PubMed ID: 37732317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive Analysis of N6-Methyladenosine RNA Methylation Regulators in the Diagnosis and Subtype Classification of Rheumatoid Arthritis.
    Zhang S; Sun S; Zhang Y; Liu J; Wu Y; Zhang X
    Biochem Genet; 2024 Oct; 62(5):3467-3484. PubMed ID: 38112894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
    Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
    Front Immunol; 2021; 12():669750. PubMed ID: 34054840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New roles of N6-methyladenosine methylation system regulating the occurrence of non-alcoholic fatty liver disease with N6-methyladenosine-modified MYC.
    Cheng W; Li M; Zhang L; Zhou C; Yu S; Peng X; Zhang W; Zhang W
    Front Pharmacol; 2022; 13():973116. PubMed ID: 36120320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.